) The Protein Microchemistry Core assists cancer researchers with all aspects relating to the isolation, purification, identification and production of peptides and proteins. Forty Cancer Center investigators from 9 of the 10 Cancer Programs have utilized the Protein Microchemistry Core since 1996. In 1999, the Protein Microchemistry Core facilities at UCHSC and the National Jewish Center were combined. The combination of these Cores resulted in the doubling of the use of microsequencing facilities over 1998 values and tripled the use of mass spectrometry services. Restructuring of the Core also added peptide synthesis as a new Core service. This service already has a significant usage rate and demand appears to be increasing. Increased use of the Core by investigators interested problems of protein structure and analysis of complex protein mixtures led to its reorganization and expansion. The expanded version of the Protein Microchemistry Core is significantly enhanced through the addition of state-of-the-art mass spectrometry, an upgrade in Edman sequencing hardware and the addition of peptide synthesis. Several mass spectrometers, including 3 electrospray ionization (ESI) systems and a matrix-assisted laser desorption ionization (MALDI) mass spectrometer combined with a Perkin Elmer Procise 494 Edman sequencer will ensure that researchers have access to the most powerful hardware currently available. The core also provides the expertise, technical resources and collaborative interactions to ensure that these instruments are optimally employed in solving the problems of the user base. The Protein Microchemistry Core, directed by Mark Duncan Ph.D., is composed of two facilities: the Proteomics Unit and the Protein Structure Unit. The Core occupies space on the University of Colorado Health Sciences Center (UCHSC) campus, and at National Jewish Center (NJC). The Core has access to all the necessary equipment to realize its objectives, but the hiring of some additional staff is necessary.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA046934-14
Application #
6491219
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
1988-03-01
Project End
2006-01-31
Budget Start
Budget End
Support Year
14
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Shearn, Colin T; Pulliam, Casey F; Pedersen, Kim et al. (2018) Knockout of the Gsta4 Gene in Male Mice Leads to an Altered Pattern of Hepatic Protein Carbonylation and Enhanced Inflammation Following Chronic Consumption of an Ethanol Diet. Alcohol Clin Exp Res 42:1192-1205
Giles, Erin D; Jindal, Sonali; Wellberg, Elizabeth A et al. (2018) Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer. Breast Cancer Res 20:50
Nemkov, Travis; Sun, Kaiqi; Reisz, Julie A et al. (2018) Hypoxia modulates the purine salvage pathway and decreases red blood cell and supernatant levels of hypoxanthine during refrigerated storage. Haematologica 103:361-372
Soontararak, Sirikul; Chow, Lyndah; Johnson, Valerie et al. (2018) Mesenchymal Stem Cells (MSC) Derived from Induced Pluripotent Stem Cells (iPSC) Equivalent to Adipose-Derived MSC in Promoting Intestinal Healing and Microbiome Normalization in Mouse Inflammatory Bowel Disease Model. Stem Cells Transl Med 7:456-467
Pennock, Nathan D; Martinson, Holly A; Guo, Qiuchen et al. (2018) Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer. J Immunother Cancer 6:98
Ross, Brian C; Boguslav, Mayla; Weeks, Holly et al. (2018) Simulating heterogeneous populations using Boolean models. BMC Syst Biol 12:64
Wang, Guankui; Benasutti, Halli; Jones, Jessica F et al. (2018) Isolation of Breast cancer CTCs with multitargeted buoyant immunomicrobubbles. Colloids Surf B Biointerfaces 161:200-209
Suda, Kenichi; Kim, Jihye; Murakami, Isao et al. (2018) Innate Genetic Evolution of Lung Cancers and Spatial Heterogeneity: Analysis of Treatment-Naïve Lesions. J Thorac Oncol 13:1496-1507
New, Melissa L; White, Collin M; McGonigle, Polly et al. (2018) Prostacyclin and EMT Pathway Markers for Monitoring Response to Lung Cancer Chemoprevention. Cancer Prev Res (Phila) 11:643-654
Vartuli, Rebecca L; Zhou, Hengbo; Zhang, Lingdi et al. (2018) Eya3 promotes breast tumor-associated immune suppression via threonine phosphatase-mediated PD-L1 upregulation. J Clin Invest 128:2535-2550

Showing the most recent 10 out of 1634 publications